Legal Opinion
In Re Fosamax Products Liability Litigation
District Court, S.D. New York
Decided July 27, 2009No. 1:06-cv-01789PublishedCited by 139 opinions
1Opinion of the Court
OPINION & ORDER
JOHN F. KEENAN, District Judge.
Currently pending in this multi-district litigation (“MDL”) are omnibus Dauberb motions filed by the Plaintiffs Steering Committee (“PSC”) and Defendant Merck & Co., Inc. (“Merck”). For the following reasons, the Court rules as follows.
I. Background 1
Merck makes and distributes Fosamax (alendronate), an FDA-approved drug widely prescribed for the treatment or prevention of osteoporosis. Fosamax belongs to a class of drugs called bisphosphonates. Bisphosphonate drugs have become standard treatment for various metabolic and oncologic diseases…
2Cases cited40 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- United States v. Paul A. BilzerianCourt of Appeals for the Second Circuit · 1991
- United States v. John W. DowningCourt of Appeals for the Third Circuit · 1985
35 more not listed; retrieve them via the Exa API.
3Cited by139 opinions
- Louis Vuitton Malletier S.A. v. Sunny Merchandise Corp.District Court, S.D. New York · 2015
- Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.Court of Appeals for the Fourth Circuit · 2018
- In re Mirena IUD Products Liability LitigationDistrict Court, S.D. New York · 2016
- In re E.I. Du Pont De Nemours & Co. C-8 Personal Injury Litig.District Court, S.D. Ohio · 2016
- Scott v. Chipotle Mexican Grill, Inc.District Court, S.D. New York · 2016
134 more not listed; retrieve them via the Exa API.